KalVista Pharmaceuticals, Inc.·4

May 27, 4:05 PM ET

Yea Christopher 4

4 · KalVista Pharmaceuticals, Inc. · Filed May 27, 2026

Research Summary

AI-generated summary of this filing

Updated

KalVista (KALV) CDO Christopher Yea Sells Shares

What Happened Christopher Yea, KalVista's Chief Development Officer, had 3,125 restricted stock units (RSUs) convert into common shares on 2026-05-22. A portion of those shares (1,966) were sold in an open-market "sell to cover" on 2026-05-26 at $26.78 each, generating $52,645 to satisfy tax withholding obligations. The RSU conversion is reported as a derivative exercise/settlement (transaction code M).

Key Details

  • Transaction dates: RSU settlement reported 2026-05-22; open-market sale on 2026-05-26. Filing date: 2026-05-27.
  • Sale detail: 1,966 shares sold @ $26.78 for proceeds of $52,645 (open-market sale, code S).
  • RSU conversion: 3,125 RSUs converted to 3,125 shares (reported as exercise/conversion, code M). One line shows a disposition at $0 related to the derivative settlement.
  • Shares owned after the transactions: Not specified in the filing.
  • Footnotes: F1—each RSU converts to one share for no consideration; F2—the reported sale was a sell-to-cover to satisfy tax withholding and not a discretionary sale by the insider; F3—RSUs vest 1/16th each quarter beginning 8/22/2024, subject to continued service.
  • Timeliness: The filing was submitted 2026-05-27. Transactions on 2026-05-22 appear to have been reported after the two-business-day SEC window (so those entries were effectively filed late by one business day), while the 2026-05-26 sale was filed promptly.

Context

  • Derivative code M indicates conversion/settlement of equity awards (here, RSUs). RSUs are not an out‑of‑pocket purchase by the insider; they convert to shares upon vesting.
  • The 1,966-share sale was a routine sell-to-cover to satisfy tax withholding tied to the RSU settlement (per footnote), which is common and not usually taken as a directional signal about the insider’s view of the company.
  • For retail investors: purchases are generally more informative than routine sell-to-cover transactions. This filing documents an RSU settlement and a tax-related sale, not a discretionary cash-raising sale by the insider.

Insider Transaction Report

Form 4
Period: 2026-05-22
Yea Christopher
CHIEF DEVELOPMENT OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-05-22+3,125231,884 total
  • Sale

    Common Stock

    [F2]
    2026-05-26$26.78/sh1,966$52,645229,918 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F3]
    2026-05-223,12525,000 total
    Common Stock (3,125 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
  • [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  • [F3]1/16th of the total restricted stock units subject to the Award shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on August 22, 2024, subject to continued service through each vesting date.
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact|2026-05-27

Documents

1 file
  • 4
    form4-05272026_040505.xmlPrimary